• Skip to main content
  • Skip to secondary menu
  • Skip to footer

Briefly.net

media intelligence

  • About
  • Sponsored Post
    • Make a Contribution
  • Job Board
  • Market Forecasts
  • Domain Marketplace
  • Contact
    • GDPR

European Scientists Zero In On AstraZeneca COVID-19 Vaccine Blood Clot Link : Coronavirus Updates : NPR

March 22, 2021 By admin Leave a Comment

A rare blood clotting condition has occurred in some people after receiving the AstraZeneca COVID-19 vaccine. If the new research is correct, it could mean that blood clots could be easily treated.
— Read on www.npr.org/sections/coronavirus-live-updates/2021/03/21/979781065/european-scientists-zero-in-on-astrazeneca-blood-clot-link

Filed Under: Brief Tagged With: covid19

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Footer

Recent Posts

  • Trump Administration Cancels $7.5 Billion in Clean Energy Projects, Garamendi Calls It Retaliation Against California
  • Colombia’s President Turns into an Anti-American Agitator
  • Cybersecurity at a Crossroads: Capital, Controls, and the AI Defense Stack
  • Datavault AI Secures $150 Million Bitcoin-Backed Investment from Scilex Holding Company
  • Global Tablet Shipments Surge 20.4% in 3Q24 Amid Renewed Market Optimism and AI Integration
  • Game Changers For Good
  • DN4B.com: Distributed Networks for Business
  • Harnessing Algae: The Future of Sustainable Transportation Fuel
  • The Environmental Impact of Beef: How Choosing Tofu Can Help Save the Planet
  • The Intersection of Market Analysis and Emerging Technologies

Media Partners

Media Instances
Event Calendar
Domain Market Research
Defense Market
Exclusive
S3H
Bootstrapping
Opinion
Market Research Media
ZGM

Media Parners

Press Media Release
DN4B
MSL
Publishing House
Media Gallery
Briefly
Agile Soft Dev
Cyber Security Market
Policymaker
Nameable

Copyright © 2022 Briefly.net